Caplin Point Laboratories Limited (BSE: 524742)
Health Care · Pharmaceuticals · IN
Rs2,558.10
+3.12% today · +18.4% 1Y
Caplin Point Laboratories Limited (BSE: 524742) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $2.03B.
Over the last twelve months the share price has gained 18.4%, trading between 1.50K and 2.70K.
Tweenvest scores Caplin Point Laboratories Limited across four factors: quality 88/100, value 22/100, growth 68/100, dividend 40/100. Its strongest factor is quality.
524742 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $2.03B
- Revenue (TTM)
- $241.91M
- P/E
- 29.31
- EPS
- 87.29
- Dividend yield
- 0.31%
- Beta (5Y)
- 0.37
- 52-week high
- Rs2,700.00
- 52-week low
- Rs1,502.45
- Avg volume (3M)
- —
- Shares outstanding
- 76.01M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.11T | $1,243.15 | -0.30% |
| Johnson & JohnsonNYSE: JNJ | $658.00B | $273.25 | +0.08% |
| Merck & Co., Inc.NYSE: MRK | $371.70B | $156.17 | +3.66% |
| Roche Holding AGSWX: ROP | $368.80B | CHF373.80 | +0.92% |
| Novartis AGSWX: NOVN | $300.52B | CHF126.76 | -0.52% |
| AstraZeneca PLCLSE: AZN | $256.25B | £124.76 | +3.02% |
| Novo Nordisk A/SCPSE: NOVO B | $206.64B | Dkr299.25 | -0.53% |
| Pfizer Inc.NYSE: PFE | $159.42B | $28.51 | +1.93% |
Figures last refreshed Aug 18, 2026.